3 hours Insider Selling: Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) CFO Sells 25,000 Shares of Stock MarketBeat
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Free Report) CFO Marc Wilson sold 25,000 shares of the company’s stock in a transaction on Thursday, September 26th. The stock was sold at an average price of $51.11, for a total transaction of $1,277,…